Surgery in Nasal Polyp Patients: Outcome After a Minimum Observation of 10 Years.

CRSwNP SNOT-22 adult onset asthma asthma chronic rhinosinusitis endoscopic sinus surgery eosinophilic-rich mucus follow-up nasal polyps outcome

Journal

American journal of rhinology & allergy
ISSN: 1945-8932
Titre abrégé: Am J Rhinol Allergy
Pays: United States
ID NLM: 101490775

Informations de publication

Date de publication:
Jul 2021
Historique:
pubmed: 7 10 2020
medline: 19 8 2021
entrez: 6 10 2020
Statut: ppublish

Résumé

Chronic rhinosinusitis with nasal polyps (CRSwNP) often requires surgery, but recurrence even after surgery is common. Recurrence rates largely vary in literature and asthma seems to be a comorbid factor. In this study, we aim to estimate disease recurrence during a long-term follow-up, together with the investigation of possible predicting and/or influencing parameters. Out of 196 patients operated for CRSwNP between 01/2000 and 01/2006, 133 patients had a follow-up of at least 10 years and could be included. The inflammatory profile at surgery was determined on nasal tissue and sinonasal secretions, and included analysis of eosinophils, eosinophilic-rich mucus (ERM) typically containing Charcot-Leyden crystals (CLC), and fungal hyphae (FH). During follow-up, recurrence, received treatments and comorbidities were collected. Out of the 133 included patients, local eosinophilia was present in 81% and ERM in 60%. Recurrence during follow-up was observed in 62%, and was associated with local eosinophilia and ERM (both p < 0.001). Asthma was present in 28% at inclusion, and 17% developed asthma after surgery during follow-up. The presence of asthma, at inclusion as well as developed during follow-up, was significantly associated with recurrence of CRSwNP (p = 0.001 for group comparison). Recurrence after CRSwNP surgery is common when a long-term follow-up is taken into account. ERM detected in sinonasal secretions at surgery seems to be a predictive factor for recurrence and need for revision surgery. Asthma is a frequently found comorbid factor in CRSwNP, develops even at higher age despite surgical treatment for CRSwNP, and is also associated with a higher recurrence rate. Sustained medical care after surgery is mandatory.

Sections du résumé

BACKGROUND BACKGROUND
Chronic rhinosinusitis with nasal polyps (CRSwNP) often requires surgery, but recurrence even after surgery is common. Recurrence rates largely vary in literature and asthma seems to be a comorbid factor.
OBJECTIVE OBJECTIVE
In this study, we aim to estimate disease recurrence during a long-term follow-up, together with the investigation of possible predicting and/or influencing parameters.
METHODS METHODS
Out of 196 patients operated for CRSwNP between 01/2000 and 01/2006, 133 patients had a follow-up of at least 10 years and could be included. The inflammatory profile at surgery was determined on nasal tissue and sinonasal secretions, and included analysis of eosinophils, eosinophilic-rich mucus (ERM) typically containing Charcot-Leyden crystals (CLC), and fungal hyphae (FH). During follow-up, recurrence, received treatments and comorbidities were collected.
RESULTS RESULTS
Out of the 133 included patients, local eosinophilia was present in 81% and ERM in 60%. Recurrence during follow-up was observed in 62%, and was associated with local eosinophilia and ERM (both p < 0.001). Asthma was present in 28% at inclusion, and 17% developed asthma after surgery during follow-up. The presence of asthma, at inclusion as well as developed during follow-up, was significantly associated with recurrence of CRSwNP (p = 0.001 for group comparison).
CONCLUSION CONCLUSIONS
Recurrence after CRSwNP surgery is common when a long-term follow-up is taken into account. ERM detected in sinonasal secretions at surgery seems to be a predictive factor for recurrence and need for revision surgery. Asthma is a frequently found comorbid factor in CRSwNP, develops even at higher age despite surgical treatment for CRSwNP, and is also associated with a higher recurrence rate. Sustained medical care after surgery is mandatory.

Identifiants

pubmed: 33019818
doi: 10.1177/1945892420961964
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

449-457

Auteurs

Stephan Vlaminck (S)

Department of Otorhinolaryngology, AZ St-Johns Hospital, Bruges, Belgium.

Frederic Acke (F)

Department of Otorhinolaryngology, University Hospital, Ghent, Belgium.

Emmanuel Prokopakis (E)

Department of Otorhinolaryngology, University of Crete School of Medicine, Crete, Greece.

Kato Speleman (K)

Department of Otorhinolaryngology, AZ St-Johns Hospital, Bruges, Belgium.

Hideyuki Kawauchi (H)

Department of Otorhinolaryngology, University Hospital, Shimane, Japan.

Jean-Christophe van Cutsem (JC)

Department of Otorhinolaryngology, AZ St-Johns Hospital, Bruges, Belgium.

Peter W Hellings (PW)

Department of Otorhinolaryngology, University Hospital, Leuven, Belgium.

Mark Jorissen (M)

Department of Otorhinolaryngology, University Hospital, Leuven, Belgium.

Sven Seys (S)

Department of Otorhinolaryngology, University Hospital, Leuven, Belgium.

Claus Bachert (C)

Department of Otorhinolaryngology, University Hospital, Ghent, Belgium.

Thibaut Van Zele (TV)

Department of Otorhinolaryngology, University Hospital, Ghent, Belgium.

Bart N Lambrecht (BN)

Laboratory of Immunoregulation, VIB Center for Inflammation Research, Ghent, Belgium.
Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Department of Pulmonary Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.

Philippe Gevaert (P)

Department of Otorhinolaryngology, University Hospital, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH